3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
CNS
2
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Glioblastoma
11
Brain Neoplasms
11
Gliosarcoma
9
Neuroblastoma
5
Astrocytoma
5
Oligodendroglioma
4
Glioma
4
Carcinoma, Renal Cell
4
Sarcoma, Ewing
3
Sarcoma
3
Rhabdomyosarcoma
3
Rhabdoid Tumor
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Wilms Tumor
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neurofibromatosis 2
2
Neurofibromatosis 1
2
Neoplasms
2
Melanoma
2
Medulloblastoma
2
Ependymoma
2
Carcinoma, Hepatocellular
2
Vestibulocochlear Nerve Diseases
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Cyclophosphamide
35
Temozolomide
33
Filgrastim
26
Etoposide
26
Carboplatin
25
Vincristine
22
Cisplatin
22
Radiotherapy
20
Magnetic Resonance Spectroscopy
18
Thiotepa
14
Irinotecan
13
Granulocyte Colony-Stimulating Factor
12
Peripheral Blood Stem Cell Transplantation
11
Lomustine
11
Specimen Handling
9
Radiation
9
Melphalan
9
etoposide phosphate
8
Topotecan
8
Methotrexate
8
X-Rays
7
Platinum
7
Phantoms, Imaging
7
sonidegib
6
Biopsy
6
1,2-diaminocyclohexaneplatinum II citrate
6
sargramostim
5
palbociclib
5
Nuclear Medicine Department, Hospital
5
HhAntag691
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Sirolimus
×
CNS
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled